BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2021
View Archived Issues
Identification and preclinical evaluation of new gamma-secretase modulators to prevent and treat AD
Read More
Brain cell alcohol metabolism affects behavior, addiction
Read More
SF-1 antagonist OR-449 for treating ACC
Read More
Actinium and MSK evaluate Iomab-ACT for targeted conditioning prior to CD19 CAR T-cell therapy
Read More
Ferro Therapeutics synthesizes new PHGPx inhibitors
Read More
HiberCell identifies PERK inhibitors
Read More
Sunshine Lake Pharma presents new TR-beta agonists
Read More
Polivy approved in Japan for relapsed or refractory DLBCL
Read More
Chinese investigators patent TRK inhibitors
Read More
Kochi University discovers new KHSRP inhibitors
Read More
Japanese approval of additional indication for Riona
Read More
Seikagaku obtains approval in Japan for Joyclu intra-articular injection
Read More
Vitrakvi approved in Japan for NTRK fusion-positive advanced or recurrent solid tumors
Read More
Vidaza receives extended approval in Japan for acute myeloid leukemia
Read More
Uplizna gains Japanese approval for the treatment of neuromyelitis optica spectrum disorder
Read More
Corectim Ointment 0.25% and 0.5% approved in Japan as treatment of pediatric atopic dermatitis
Read More
Treakisym in combination with rituximab approved in Japan as treatment of R/R DLBCL
Read More
Microvesicles promote infarct recovery in primates
Read More
Guerbet reports positive phase III data for gadopiclenol
Read More
AstraZeneca reports primary analysis of U.S. phase III trial of AZD-1222
Read More
First patient dosed in phase I study of TH-1902 as treatment of sortilin-positive solid tumors
Read More
Synlogic achieves proof of mechanism for SYNB-8802 in dietary hyperoxaluria study
Read More
Positive topline data from phase II study of NurOwn as treatment of progressive MS
Read More
Phase II/III study of relatlimab with nivolumab in melanoma meets PFS primary endpoint
Read More
KM Biologics reports phase I data on tetravalent dengue vaccine KD-382
Read More